These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 28488260

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation.
    Robinson CA, Inci I, Naegeli M, Murer C, Schuurmans MM, Urosevic-Maiwald M, Schüpbach R, Weder W, Benden C.
    Pediatr Transplant; 2018 May; 22(3):e13145. PubMed ID: 29380491
    [Abstract] [Full Text] [Related]

  • 23. Lung transplantation and extracorporeal photopheresis: The answer to bronchiolitis obliterans?
    Yung GL, Craig V.
    Transfus Apher Sci; 2015 Apr; 52(2):162-6. PubMed ID: 25881738
    [Abstract] [Full Text] [Related]

  • 24. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL, Neely ML, Finlen Copeland CA, Frankel CW, Reynolds JM, Palmer SM.
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [Abstract] [Full Text] [Related]

  • 26. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A, Todd JL, Zhang A, Li N, Mayalall A, Finlen Copeland CA, Shino M, Pavlisko EN, Wallace WD, Gregson A, Ross DJ, Saggar R, Lynch JP, Belperio J, Snyder LD, Palmer SM, Weigt SS.
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [Abstract] [Full Text] [Related]

  • 27. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Königshoff M, Weig T, Schramm R, Winter H, Behr J, Neurohr C.
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [Abstract] [Full Text] [Related]

  • 28. A new classification system for chronic lung allograft dysfunction.
    Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P.
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
    Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, Olland A, Kessler R, Renaud-Picard B.
    Respir Med Res; 2022 May; 81():100913. PubMed ID: 35525096
    [Abstract] [Full Text] [Related]

  • 31. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP, Shlobin OA, Barnett SD, Burton N, Nathan SD.
    J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S, Yamamoto H, Kurosaki T, Otani S, Okazaki M, Yamane M, Toyooka S, Oto T.
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [Abstract] [Full Text] [Related]

  • 34. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
    Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M.
    Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis.
    Salerno CT, Park SJ, Kreykes NS, Kulick DM, Savik K, Hertz MI, Bolman RM.
    J Thorac Cardiovasc Surg; 1999 Jun; 117(6):1063-9. PubMed ID: 10343253
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M, Langer KJ, Khera N, Adamski J, Roy V, Winters JL, Gastineau DA, Jacob EK, Kreuter JD, Gandhi MJ, Hogan WJ, Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM.
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
    [Abstract] [Full Text] [Related]

  • 39. Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.
    Piloni D, Morosini M, Magni S, Balderacchi A, Scudeller L, Cova E, Oggionni T, Stella G, Tinelli C, Antonacci F, D'Armini AM, Meloni F.
    BMC Pulm Med; 2017 Jul 18; 17(1):102. PubMed ID: 28720146
    [Abstract] [Full Text] [Related]

  • 40. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Teszak T, Assabiny A, Kiraly A, Tarjanyi Z, Parazs N, Szakal-Toth Z, Hartyanszky I, Szabolcs Z, Racz K, Reti M, Merkely B, Sax B.
    Transpl Immunol; 2023 Aug 18; 79():101853. PubMed ID: 37196865
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.